Another new basal insulin, degludec, is available in Japan

Japan has approved use of a new basal insulin from Novo Nordisk, insulin degludec.  It is being promoted by the company as having a duration of action up to 42 hours.  The press release is here.

Advertisements

About Aaron Neinstein, MD
I'm an Assistant Professor in Endocrinology and Director of Clinical Informatics at the University of California, San Francisco.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: